Telangiectasia, hereditary hemorrhagic, type 1
MONDO:0008535Also known as: HHT1, hereditary hemorrhagic telangiectasia type 1, telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber, telangiectasia, hereditary hemorrhagic, type 1, ENG-related Hereditary hemorrhagic telangiectasia, HHT, ORW disease, Osler Weber Rendu syndrome type 1
9 clinical trials for this condition and its sub-types, 4 tagged with Telangiectasia, hereditary hemorrhagic, type 1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could a cancer pill stop debilitating nosebleeds? new trial hopes so.
Disease control OngoingThis study tests whether a low dose of pazopanib, a drug currently used for cancer, can reduce severe nosebleeds and improve anemia in people with hereditary hemorrhagic telangiectasia (HHT). About 70 participants will take either the drug or a placebo daily for 24 weeks. Researc…
Phase 2/3 • Sponsor: Cure HHT • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New registry aims to unlock secrets of rare bleeding disorder
Knowledge-focused OngoingThis study is creating a registry of people with Hereditary Hemorrhagic Telangiectasia (HHT), a rare condition that causes abnormal blood vessels and frequent nosebleeds. Researchers will collect health information from about 1,000 adults over many years to see how the disease ch…
Sponsor: Unity Health Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC